To view the investor presentation please click here.
A recording of the presentation can be accessed via the following link:
https://webcasting.buchanan.uk.com/broadcast/5fd23c59ca22cd76f9d3c662/5ff5a61365d56b44935101d1
January 2021: To view the corporate presentation please click here.
To view the corporate presentation please click here.
15 September 2020: ReNeuron’s CEO, Olav Hellebo presents virtually at the H. C. Wainwright 22nd Annual Global Investment Conference.
To login and view the webcast please click here.
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
https://webcasting.buchanan.uk.com/broadcast/5f154afa4c167c1215797e02
11 June 2020: ReNeuron Group’s (LON:RENE) Michael Hunt pitches the company to investors at the Proactive One2One Virtual Event. The company’s a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
To view the link please CLICK HERE.
